Publicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (11)

2024

  1. Impact of liver diseases and pharmacological interactions on the transportome involved in hepatic drug disposition

    Biochemical Pharmacology

2012

  1. Characterization of the role of ABCG2 as a bile acid transporter in liver and placenta

    Molecular Pharmacology, Vol. 81, Núm. 2, pp. 273-283

  2. Chemoprevention, chemotherapy, and chemoresistance in colorectal cancer

    Drug Metabolism Reviews, Vol. 44, Núm. 2, pp. 148-172

  3. No correlation between the expression of FXR and genes involved in multidrug resistance phenotype of primary liver tumors

    Molecular Pharmaceutics, Vol. 9, Núm. 6, pp. 1693-1704

  4. Up-regulation of FXR isoforms is not required for stimulation of the expression of genes involved in the lack of response of colon cancer to chemotherapy

    Pharmacological Research, Vol. 66, Núm. 5, pp. 419-427

2011

  1. Further characterization of the electrogenicity and ph sensitivity of the human organic anion-transporting polypeptides OATP1B1 and OATP1B3

    Molecular Pharmacology, Vol. 79, Núm. 3, pp. 596-607

2010

  1. Molecular bases of liver cancer refractoriness to pharmacological treatment

    Current Medicinal Chemistry, Vol. 17, Núm. 8, pp. 709-740

2009

  1. Hepatobiliary transporters in the pharmacology and toxicology of anticancer drugs

    Frontiers in Bioscience, Vol. 14, Núm. 11, pp. 4257-4280

  2. Importance and limitations of chemotherapy among the available treatments for gastrointestinal tumours

    Anti-Cancer Agents in Medicinal Chemistry, Vol. 9, Núm. 2, pp. 162-184

  3. Overview of the molecular bases of resistance to chemotherapy in liver and gastrointestinal tumours

    Current Molecular Medicine, Vol. 9, Núm. 9, pp. 1108-1129

2006

  1. OATP8/1B3-mediated cotransport of bile acids and glutathione: An export pathway for organic anions from hepatocytes?

    Journal of Biological Chemistry, Vol. 281, Núm. 41, pp. 30326-30335